Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Abl Y213-p
CDK1 S216-p
ERK1 S183-p , S216-p , S225-p , T265-p , S267-p , S392-p , T394-p , S410-p
ERK2 S183-p , S216-p , S225-p , T265-p , S267-p , S392-p , T394-p , S410-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Abl Y213-p
CDK1 S216-p
ERK2 S183-p , S225-p
Regulatory protein:
Abl Y213-p
Bcr Y213-p
FGFR1 Y198-p
JAM-A S225-p
Treatment:
angiotensin_2 S222-p
CI1040 S225-p
dasatinib S222-p
EGF S183-p , S216-p , S225-p , S392-p , T394-p , S410-p
ephrin_B1 Y198-p , Y213-p
ephrin_B2 Y213-p , Y333-p
erlotinib Y213-p
FGF2 Y198-p
gefitinib S323-p
HGF Y198-p , Y213-p
imatinib Y213-p , Y435-p
ischemia S222-p , S225-p , S323-p
metastatic potential S222-p , S225-p
nocodazole S216-p , S222-p , S225-p
PI-103 S231-p
PP2 S225-p
rapamycin S225-p , S231-p
seliciclib S216-p
serum_starvation S183-p , S216-p , S225-p , S392-p , T394-p , S410-p
Su11274 Y23-p , Y198-p , Y213-p , S231-p , S338-p , Y431-p
U0126 S225-p
vanadate Y213-p
wortmannin S225-p , S231-p